AMGEN INC

For the period ended Jun 30, 2024. Filed Aug 7, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 7, 2024

AMGN$465.230.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

CONDENSED CONSOLIDATED BALANCE SHEETS

	June 30, 2024	December 31, 2023
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$9,301	$10,944
Trade receivables, net	6,934	7,268
Inventories	7,995	9,518
Other current assets	2,976	2,602
Total current assets	27,206	30,332
Property, plant and equipment, net	6,097	5,941
Intangible assets, net	30,172	32,641
Goodwill	18,616	18,629
Other noncurrent assets	8,816	9,611
Total assets	$90,907	$97,154
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$2,267	$1,590
Accrued liabilities	13,722	15,359
Current portion of long-term debt	5,528	1,443
Total current liabilities	21,517	18,392
Long-term debt	57,117	63,170
Long-term deferred tax liabilities	1,780	2,354
Long-term tax liabilities	2,205	4,680
Other noncurrent liabilities	2,363	2,326
Contingencies and commitments
Stockholders’ equity:
Common stock and additional paid-in capital; $0.0001 par value; 2,750.0 shares authorized; outstanding—537.2 shares in 2024 and 535.4 shares in 2023	33,204	33,070
Accumulated deficit	(27,124)	(26,549)
Accumulated other comprehensive loss	(155)	(289)
Total stockholders’ equity	5,925	6,232
Total liabilities and stockholders’ equity	$90,907	$97,154

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.